Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$8,900,003
+$1,255,666 QoQ
Shares Held
35,368
+0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#982
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. ABBV ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,900,003 | 35,368 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $7,644,337 | 35,148 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $8,054,957 | 35,253 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $8,163,405 | 35,257 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $6,544,403 | 35,257 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $7,379,293 | 35,220 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $6,348,687 | 35,727 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $6,669,096 | 33,771 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $6,281,919 | 36,625 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $6,683,797 | 36,704 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $5,758,529 | 37,159 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $4,971,299 | 33,351 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $4,498,634 | 33,390 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $5,477,386 | 34,369 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $5,570,050 | 34,466 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $4,650,376 | 34,650 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $5,259,667 | 34,341 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $5,765,441 | 35,565 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,182,448 | 8,733 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $978,057 | 9,067 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $1,032,527 | 9,541 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $1,022,318 | 9,541 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $863,287 | 9,856 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,024,802 | 10,438 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $763,728 | 10,024 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||